The latest leukaemia news
A new study will enable clinicians to identify patients with aggressive leukaemia who will not…
By analysing 442 samples from three groups of children and adults with acute myeloid leukaemia…
New tailored therapies offer exciting prospects for treating acute myeloid leukaemia (AML), but taking advantage…
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was…
Acute myeloid leukaemia (AML) is an aggressive cancer of the blood-forming system. It affects the…
B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by the accumulation of abnormal immature B-cell precursors…
A team of researchers at University of California San Diego School of Medicine and Moores…
First validated prognostic score offers valuable insights for patients advised to ‘watch and wait’ A…
Analyses of cell signals provide insight into the origin of severe inflammatory symptoms that appear…
A study published in the journal Oncotarget has reported a preclinical study, which has characterised the binding…